Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Name (Synonyms) | Correlation |
---|
Name (Synonyms) | Correlation | |
---|---|---|
D014115 | Toxemia NIH | 0.45 |
D018805 | Sepsis NIH | 0.35 |
D011024 | Pneumonia, Viral NIH | 0.11 |
Name (Synonyms) | Correlation | |
---|---|---|
HP:0100806 | Sepsis HPO | 0.35 |
HP:0002090 | Pneumonia HPO | 0.05 |
Navigate: Correlations HPO
There is one clinical trial.
This prospective observational pilot study investigates circulatory coherence in patients with COVID and non-COVID sepsis by comparison of microcirculation, endothelial glycocalyx, and clinical course
Description: PPV describes microcirculation dysfunction
Measure: change in Proportion of Perfused Vessels (PPV) parameter Time: 1st, 2nd and 3rd dayDescription: Syndecan-1 is a marker of endothelial glycocalyx
Measure: change in Syndecan-1 serum concentration Time: 1st, 2nd and 3rd dayDescription: albuminuria is a marker of glomerular endothelial cells dysfunction
Measure: change in albuminuria Time: 1st, 2nd and 3rd dayDescription: mortality in 28 days from ICU admission
Measure: mortality in 28 days Time: 30 daysAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on December 13, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports